Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Impax Laboratories is recalling specific lots of Dextroamphetamine Sulfate Tablets because they failed impurity and degradation specifications.
Hospira Inc. is recalling 22,292 bags of Mannitol I.V. 20% due to potential contamination with an aromatic hydrocarbon resin.
Hospira is recalling 11,256 bags of Dextrose Injection, USP, 70% due to potential contamination with an aromatic hydrocarbon resin.
Hospira Inc. is recalling 1,776 bags of Aminosyn-PF (amino acids) 7% due to potential contamination with an aromatic hydrocarbon resin.
AbbVie is recalling 307 bottles of Zemplar (paricalcitol) capsules nationwide because the product failed content uniformity specifications.
Torrent Pharmaceuticals is recalling Telmisartan 80 mg tablets because a product complaint identified silicone foreign matter within the tablets.
Fresenius Kabi is recalling 94,560 vials of Cisatracurium Besylate Injection because the carton labels incorrectly state the product is preservative-free.
Biocon Inc is voluntarily recalling 5,505 bottles of Simvastatin Tablets USP 5 mg because the drug was found to be subpotent. The affected lots were distributed in Pennsylvania, California, and Ohio.
Amerisource Health Services is recalling 228 cartons of Fenofibrate Capsules because some units have incorrect or missing lot and expiration dates.
Impax Laboratories is recalling 28,001 bottles of Fenofibrate Capsules (Micronized) 134 mg because the bottles have incorrect or missing lot and expiration dates.
Fresenius Kabi USA, LLC is recalling Haloperidol Decanoate Injection due to an impurity out-of-specification result. The recall affects 48,210 units distributed nationwide and in Puerto Rico.
Amerisource Health Services is recalling 5,034 cartons of Fenofibrate Capsules (Micronized), 200 mg, due to incorrect or missing lot and expiration dates.
Impax Laboratories is recalling 42,239 bottles of Fenofibrate Capsules (Micronized) 200 mg because some bottles have incorrect or missing lot and expiration dates.
Meditech Laboratories is recalling Formula 4 Injection vials due to incomplete data regarding production sterility.
Meditech Laboratories is recalling Formula 2 vials because an active ingredient expired before the labeled Beyond Use Date.
Actavis is recalling specific lots of amphetamine tablets because they failed impurity specifications. Consumers should stop using the product and contact their pharmacist.
Actavis Elizabeth LLC is recalling 257,746 bottles of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 20 mg, because they failed impurity specifications.
Meditech Laboratories is recalling Formula 9 Injection vials due to incomplete production data regarding sterility assurance.
Meditech Laboratories is recalling Formula 0 Injection due to incomplete production data regarding sterility assurance.
Meditech Laboratories is recalling Formula 2 Injection vials because one ingredient exceeded assay specifications, making the drug superpotent.
Purdue Pharma is recalling Intermezzo (zolpidem tartrate) sublingual tablets because they failed to meet dissolution specifications.
Meditech Laboratories is recalling Formula 3 Injection vials because the active ingredient expired before the labeled Beyond Use Date.
Meditech Laboratories is recalling 1,320 vials of Formula 1 Injection because the active ingredient expired before the labeled Beyond Use Date.
Actavis Elizabeth LLC is recalling 182,378 bottles of 30 mg Dextroamphetamine and Amphetamine tablets because they failed impurity specifications.
Actavis is recalling specific lots of 10 mg dextroamphetamine tablets because they failed impurity specifications. The recall covers 114,388 bottles distributed nationwide.